Stocks and Investing Stocks and Investing
Tue, May 2, 2017

RAIL, SSRI, ARTNA, HR, FRT, NKTR Expected To Be Down After Next Earnings Releases


Published on 2017-05-02 00:45:11 - WOPRAI
  Print publication without navigation


May 2, 2017 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Wednesday, May 3rd 2017 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and earnings reports. Freightcar America Inc. (NASDAQ:RAIL), Silver Standard Resources, Inc. (NASDAQ:SSRI), Artesian Resources Corporation - Class A Non (NASDAQ:ARTNA), Healthcare Realty Trust Inc. (NYSE:HR), Federal Realty Investment Trust (NYSE:FRT), Nektar Therapeutics (NASDAQ:NKTR) are all expected to be Down After their earnings are released Wednesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Wednesday:

  Symbol  Company                          # of Reports         Quarter  Release Time
  RAIL    Freightcar America Inc.          May Earnings         Q1       After
  SSRI    Silver Standard Resources, Inc.  May Earnings         Q1       After
  ARTNA   Artesian Resources Corporation  -  Class A Non  May Earnings         Q1       After
  HR      Healthcare Realty Trust Inc.     May Earnings         Q1       After
  FRT     Federal Realty Investment Trust  May Earnings         Q1       After
  NKTR    Nektar Therapeutics              May Earnings         Q1       After
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Freightcar America Inc. (NASDAQ:RAIL) - FreightCar America, Inc., through its subsidiaries, designs, manufactures, and sells railcars for the transportation of bulk commodities and containerized freight products primarily in North America. The company offers a range of freight cars, including open top hoppers, covered hoppers, and gondolas; intermodal flats, such as well cars; and non-intermodal flat cars comprising slab, hot slab, ribbon rail, and bulkhead flats. It also provides stainless steel and hybrid stainless steel, and aluminum-bodied railcars, such as coal cars; and mill gondolas, coil gondolas, triple hoppers, ore hoppers, ballast hopper cars, aggregate hopper cars, boxcars, woodchip hoppers, aluminum vehicle carriers, and articulated bulk container railcars. In addition, the company leases freight cars; refurbishes and rebuilds railcars; and sells forged, cast, and fabricated parts for various railcars. It also exports its manufactured railcars to Latin America and the Middle East. The company s customers primarily include railroads, shippers, and financial institutions. FreightCar America, Inc. was founded in 1901 and is headquartered in Chicago, Illinois..

Silver Standard Resources, Inc. (NASDAQ:SSRI) - Silver Standard Resources Inc. engages in the acquisition, exploration, development, and operation of precious metal resource properties in the Americas. The company primarily explores for gold and silver deposits. Its projects include the Marigold mine located in Humboldt County, Nevada, the United States; the Pirquitas mine located in the province of Jujuy, northern Argentina; and the Seabee Gold Operation located near Laonil Lake, Saskatchewan. The company was formerly known as Consolidated Silver Standard Mines Limited and changed its name to Silver Standard Resources Inc. in April 1990. Silver Standard Resources Inc. was founded in 1946 and is based in Vancouver, Canada..

Artesian Resources Corporation - Class A Non (NASDAQ:ARTNA) - Artesian Resources Corporation, through its subsidiaries, provides water, wastewater, and other services on the Delmarva Peninsula. The company distributes and sells water to residential, commercial, industrial, municipal, and utility customers in the states of Delaware, Maryland, and Pennsylvania. It also offers water for public and private fire protection to customers in its service territories. In addition, the company provides contract water and wastewater services, water and sewer service line protection plans, and wastewater management services, as well as design, construction, and engineering services. As of December 31, 2016, it served approximately 82,700 metered water customers through 1,260 miles of transmission and distribution mains. The company was founded in 1905 and is headquartered in Newark, Delaware..

Healthcare Realty Trust Inc. (NYSE:HR) - Healthcare Realty Trust Incorporated is an independent real estate investment trust. The firm invests in real estate markets of the United States. It primarily engages in ownership, acquisition, management, leasing, and development of properties associated with delivery of healthcare services such as medical office and outpatient facilities. The firm also provides mortgage financing on healthcare facilities. Healthcare Realty Trust Incorporated was formed in 1992 and is based Nashville, Tennessee..

Federal Realty Investment Trust (NYSE:FRT) - Federal Realty Investment Trust operates as a real estate investment trust, which engages in the ownership, management, development, and redevelopment of retail and mixed-use properties. As of June 30, 2005, it owned or had a majority interest in 103 community and neighborhood shopping centers, and retail mixed-use properties (excluding joint venture properties) comprising approximately 17.4 million square feet located primarily in strategic metropolitan markets in the Northeast, Mid-Atlantic, and California. In addition, it had 30% interest in approximately 0.5 million square feet of retail space through its joint venture with an affiliate of Clarion Lion Properties Fund, and one apartment complex in Maryland. The company has elected to be taxed as a REIT. As a REIT, it is not subject to federal income tax on taxable income that it distributes to its shareholders. The company was founded in 1962 and is headquartered in Rockville, Maryland..

Nektar Therapeutics (NASDAQ:NKTR) - Nektar Therapeutics develops drug candidates based on its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising cancer, auto-immune disease, and chronic pain. The company offers MOVANTIK, an oral peripherally-acting opioid antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain; MOVENTIG for the treatment of opioid-induced constipation in adult patients who have an inadequate response to laxatives; and ADYNOVATE for use in treating Hemophilia A. Its drug candidates in clinical development stage comprises BAY41-6551, which is in Phase III clinical trial to treat gram-negative pneumonias; NKTR-214 that is in Phase 1/2 stage to treat cancer; NKTR-181 that is in Phase III clinical trial for treating chronic pain; and NKTR-358 to treat autoimmune diseases. The company s drug candidates in clinical development stage also include ONZEALD, a topoisomerase I inhibitor that is in Phase III clinical trial for metastatic breast cancer, as well as completed Phase II clinical trial stage for refractory ovarian cancer and second-line metastatic colorectal cancer; and in combination with 5-fluorouracil/leucovorin to treat refractory solid tumor cancers, which has completed Phase I clinical trial. In addition, it holds license, manufacturing, and supply agreements with Ophthotech Corporation for Fovista; and UCB Pharma for dapirolizumab pegol. Further, the company holds a range of license, manufacturing, and supply agreements with other biotechnology and pharmaceutical companies, including Amgen Inc.; Allergan, Inc.; Merck & Co., Inc.; Pfizer, Inc.; and F. Hoffmann-La Roche Ltd (Roche). Nektar Therapeutics was founded in 1990 and is headquartered in San Francisco, California..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net


Contributing Sources